Onconetix annual gross margin
2023
2024
2025
Onconetix Gross Margin Growth & History (ONCO)
Onconetix's gross margin was 77.62% for fiscal 2025.
View full Onconetix company overviewOnconetix annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 77.62% | +35.82 pp |
| 2024 | 2024-12-31 | 41.80% | +1969.73 pp |
| 2023 | 2023-12-31 | −1,927.93% | — |
Onconetix quarterly gross margin
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 25.13% | −41.07 pp |
| Q1 2026 | 2026-03-31 | −7.71% | −52.81 pp |
| Q4 2025 | 2025-12-31 | 81.58% | −11.11 pp |
| Q3 2025 | 2025-09-30 | 88.55% | +62.64 pp |
| Q2 2025 | 2025-06-30 | 66.20% | +51.91 pp |
| Q1 2025 | 2025-03-31 | 45.10% | +18.11 pp |
| Q4 2024 | 2024-12-31 | 92.70% | — |
| Q3 2024 | 2024-09-30 | 25.91% | — |
| Q2 2024 | 2024-06-30 | 14.29% | — |
| Q1 2024 | 2024-03-31 | 26.98% | — |
Onconetix gross margin trends
Across the available reported history, Onconetix's gross margin increased from 41.80% to 77.62%, a change of +35.82 percentage points. The latest reported quarter, Q2 2026, shows 25.13%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Onconetix filings at SEC.gov ↗